Related Experiment Video
Updated: Oct 22, 2025

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis
Published on: June 18, 2020
Kidney biopsy chronicity grading in antineutrophil cytoplasmic antibody-associated vasculitis
Marta Casal Moura1, Fernando C Fervenza2, Ulrich Specks1
1Department of Medicine, Division of Pulmonary and Critical Care, Mayo Clinic College of Medicine and Science, Rochester, MN, USA.
Insights
Chronic kidney disease changes on biopsy predict outcomes in ANCA-associated vasculitis with glomerulonephritis (AAV-GN). The Mayo Clinic Chronicity Score (MCCS) effectively predicts kidney failure and survival, aiding clinical decisions.
Area of Science:
- Nephrology
- Immunology
- Pathology
Background:
- Kidney biopsy is crucial for prognostication in ANCA-associated vasculitis with glomerulonephritis (AAV-GN).
- The impact of chronic histological changes on renal outcomes in AAV-GN requires further determination.
Purpose of the Study:
- To validate and evaluate the Mayo Clinic Chronicity Score (MCCS) for outcome prediction in AAV-GN.
- To assess the independent predictive value of chronic kidney changes on renal function and survival.
Main Methods:
- Retrospective cohort study of 329 myeloperoxidase (MPO)- or proteinase 3 (PR3)-ANCA-positive patients with AAV and active renal disease.
- Application and validation of the Mayo Clinic Chronicity Score (MCCS) using kidney biopsy data.
- Analysis of correlations between MCCS grades, renal function (eGFR), and clinical outcomes (kidney failure, death).
Main Results:
- MCCS grades significantly correlated with impaired renal function at presentation (P < 0.0001).
- Higher MCCS scores were associated with lower eGFR, reduced renal recovery, and increased risk of kidney failure and death (P < 0.0001).
- MCCS effectively stratified renal outcomes and identified a cutoff (MCCS ≥4) for kidney failure prediction.
Conclusions:
- Chronic changes on kidney histology independently predict renal function, outcomes, and treatment response in AAV-GN.
- The MCCS is a valuable tool for prognostic assessment and clinical decision-making in AAV-GN.
- Histological chronicity assessment aids in predicting kidney failure risk.
Background:
Kidney biopsy is valuable for prognostic assessment of renal outcomes in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) with glomerulonephritis (AAV-GN) but the impact of chronic changes is not determined.
Methods:
We conducted a retrospective cohort study of myeloperoxidase (MPO)- or proteinase 3 (PR3)-ANCA-positive patients with AAV and active renal disease. We applied the Mayo Clinic Chronicity Score (MCCS) and validated and evaluated its implications on outcome prediction in AAV-GN.
Results:
We analyzed 329 patients with kidney biopsies available to score. The extent of chronicity was graded by MCCS as minimal [102 (31.0%)], mild [106 (32.2%)], moderate [86 (26.1%)] and severe [35 (10.6%)]. The MCCS grades correlated with the degree of renal function impairment at presentation [mean estimated glomerular filtration rate (eGFR) 48.3 versus 29.2 versus 23.7 versus 18.5 mL/min/1.73 m2, respectively; P < 0.0001]. Higher degrees of the individual components of the MCCS (glomerulosclerosis, interstitial fibrosis, tubular atrophy and arteriosclerosis) were associated with lower median eGFR (P < 0.0001) and decreased event-free [kidney failure (KF) and death] survival (P = 0.002, P < 0.0001, P < 0.0001 and P = 0.017, respectively). Patients with lower MCCS grades recovered renal function more frequently (P < 0.0001). Increasing MCCS grades were associated with decreased renal recovery (P = 0.001), more frequent events and shorter time to KF (P < 0.0001), KF and death (P < 0.0001) and death (P = 0.042), independent of the remission induction treatment used (cyclophosphamide or rituximab). The MCCS stratified renal outcomes for each MCCS grade and can be used in clinical practice as a cutoff for KF prediction (MCCS ≥4).
Conclusions:
Chronic changes on kidney histology independently predict renal function, outcomes and response to treatment in AAV-GN.
Related Concept Videos
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease III: Interprofessional Care
Chronic Kidney Disease II: Clinical Manifestations
Acute Kidney Injury II: Pathophysiology
Acute Kidney Injury I: Introduction

